Metabolic syndrome, wherein patients have both diabetes mellitus and dyslipidemia, is reaching epidemic proportions due to dietary factors and sedentary lifestyles.
Adipocytes accumulate energy in the form of triacylglycerols, which can be hydrolyzed and released as glycerol plus free fatty acids. When energy intake is dominant, excess lipid storage in white adipose tissues can be established through an increase in the size of mature adipocytes and/or recruitment of preadipocytes. This situation may lead not only to obesity but also to related pathophysiological conditions, such as type 2 diabetes mellitus, since adipose tissues are not only insulin-responsive tissues that convert glucose into fat stores, but also endocrine organs participating in energy balance regulation. 6, 7) Adipogenesis has been extensively studied in vitro using murine preadipocyte lineages and rat white adipocytes. Adipose conversion from such fibroblastic precursors is divided into at least three steps, namely cell commitment, clonal amplification and phenotype expression. 8) The initial step involves the induction of expression of several adipose-specific genes, whereas later events result in the appearance of the functional characteristics of mature adipocytes, such as increased glucose transport capacity, through the expression of insulin-responsive glucose transporters, which represent a key step in lipogenesis, thereby leading to progressive lipid accumulation. As a key factor for controlling the adipose mass in adipocytes, examination of the inhibitory activities of substances on excess lipid storage in white adipocytes represents a rational strategy for preventing obesity.
Orengedokuto (OGT), Bofutsushosan (BTS) and Boiogito (BOT) are well-known Japanese, Korean and Chinese traditional herbal medicines used to clinically prevent or improve obesity. BTS has been reported to inhibit atherosclerosis, 9) obesity, 10) hypertension 11) and hyperglycemia. 12) However, pharmacological evidence for the anti-obesity effects of OGT and BOT remains obscure. Using the well-established experimental model of excess lipid storage in cultured rat white adipocytes, we compared the pharmacological efficacies of OTG, BOT and BTS, and then investigated their effects on the expression levels of target genes responsible for obesity using DNA microarray analyses. Fig. 1 . Test samples were dissolved in phosphate-buffered saline (PBS) and sterilized with a membrane filter (pore size: 0.22 mm). Various concentrations of the test samples were added to cultured rat white adipocytes.
MATERIALS AND METHODS

Kampo Medicines and Test Sample Preparation
Cell Culture and Test Sample Treatment Rat white preadipocytes (RWPA) isolated from SD rats were purchased from TaKaRa Bio (Tokyo, Japan). RWPA were plated on type I collagen-coated dishes and cultured in serum-free Dulbecco's modified Eagle's medium supplemented with 10 mg/ ml insulin at 37°C in a humidified atmosphere containing 5% CO 2 . Differentiation into adipocytes was achieved by incubating subconfluent undifferentiated white adipocytes with 10 mg/ml insulin, 2.5 mM dexamethasone and 0.5 mM 3-isobutyl-1-methylxanthine for 2 d. The medium was then replaced with medium containing 10 mg/ml insulin. All experiments with white adipocytes were performed within two passages. In the second experiment, cells on the seventh day of white adipocyte differentiation were incubated with various concentrations of the test samples or medium as a control.
Measurement of Adipogenesis in Cultured RWPA Intracellular lipid accumulation in RWPA was measured using a commercially available kit (AdipoRed TM ; Cambrex Bio, Walkersville, MD, U.S.A.) according to the manufacturer's instructions. This kit determined the effects of the test samples on the differentiation of adipocyte precursors based on the accumulation of intracellular triglycerides. Briefly, cell culture plates were washed twice with ice-cold PBS after completion of the experiment, and the cells were stained with AdipoRed reagent containing Nile Red. After 10 min, the fluorescence intensity of each well was measured using a U-3200 fluorophotometer (Hitachi, Tokyo, Japan) with excitation at 485 nm and emission at 538 nm. Intracellular lipid accumulation was calculated and indicated as the relative fluorescence units (RFU).
DNA Microarray Analysis 13) Total RNA was isolated from the cells using a commercially available kit (RNeasy Mini Kit; QIAGEN GmbH, Hilden, Germany). The isolated RNA was quantified by photometry at 260/280 nm, and the quality of the RNA was determined by the ratio of the 18S/28S ribosomal band intensities in an ethidium bromidecontaining 1% agarose gel after electrophoresis. Preparation of cRNAs was carried out using a MessageAmp ® II-Biotin Enhanced Kit (Ambion, Austin, TX, U.S.A.) and target hybridizations were performed using a Rat 230 2.0 GeneChip ® microarray system (Affymetrix, High Wycombe, U.K.) according to the manufacturer's instructions. Double-stranded cDNAs were synthesized from 5 mg of total RNA and hybridized to the Affymetrix GeneChip ® array for 16 h at 45°C in a GeneChip ® Hybridization Oven 640. After washing and staining in a GeneChip ® Fluidics Station 450, the hybridized cRNAs were detected using a GeneChip ® Scanner 3000. The digitalized image data were processed using the GeneChip ® Operating Software (GCOS) version 1.4. The amounts of probe-specific transcripts were determined based on the average of the differences between the perfect-match and mismatch intensities. Since replicate assays were not performed, the signal intensities of selected genes that were upregulated or downregulated by at least 2-fold compared to a sham-control group were extracted by the GeneSpring GX software package version 7.3.1 (Agilent Technologies, Santa Clara, CA, U.S.A.). Ingenuity Pathway Analysis (IPA; Ingenuity Systems Inc., Redwood City, CA, U.S.A.) was used as an additional method for evaluating the functional significance of the drug-induced gene profiles. Fisher's exact test was used to calculate p values to determine the probabilities that the biological functions assigned to the different networks could be explained by chance alone.
Semiquantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) for Gene Expression Semiquantitative RT-PCR analyses were performed by the methods described previously, 14) and PrimeScript one step RT-PCR kit version 2 (Takara Bio Inc., Otsu, Japan) was used. The sequences of the primers are shown in Table 1 . Firststrand cDNAs were synthesized by 1 cycle of reverse transcription at 50°C for 30 min and 1 cycle of reverse transcriptase inactivation at 94°C for 2 min. Second-strand cDNA synthesis and PCR amplification for acetyl-Coenzyme A carboxylase alpha (ACACA), AE binding protein 1 (AEBP1), patatin-like phospholipase domain containing 8 (PNPLA8), secretoglobin (SCGB1A1), adrenergic (ADRB3), adiponectin (ADIPOQ), monoglyceride lipase (MGLL) were carried out at 94°C for 30 s, 53-57°C for 30 s and 72°C for 1 min. For each combination of primers, the kinetics of the PCR amplification was determined beforehand and semi-quantitative PCR was performed in the exponential range. The beta-Actin (ACTB) gene was used as an endogenous internal standard, and amplified with specific primers at the same time. The PCR products were electrophoresed in a 1% agarose gel and visualized by ethidium bromide staining under UV-irradiation.
Data Analysis Data were analyzed using statistical analysis methods and graphing software (KaleidaGraph TM ; Synergy Software, Tokyo, Japan). All data are expressed as the meanϮstandard deviation (S.D.). The significance of differences among values was determined by Dunnett's multiple test after one-way analysis of variance (ANOVA) in comparison with control cultures, and values of pϽ0.05 were considered to indicate significance. Furthermore, Fisher's exact test was used to calculate a p value to determine the probability that the biological function assigned to each network could be explained by chance alone.
RESULTS
PDA-HPLC Profiles of Kampo Medicines
As depicted in Fig. 1 , PDA-HPLC analyses revealed broad peaks of chemical constituents for the three Kampo medicines that appeared at various retention times (Figs. 1A-C) . UV and LC-MS/MS analyses of reference compounds indicated the presence of the following known active ingredients of BOT, BTS and OGT: isoquinoline alkaloids sinomenine (Fig. 1A) and magnoflorine (Figs. 1A, C) from rhizomes of Sinomenium acutum and Coptis japonica; triterpene glycosides glycyrrhizin (Figs. 1A, B) and flavone glycoside liquiritin from Glycyrrhiza (Figs. 1A, B) ; iridoid glucoside geniposide (Figs. 1B, C) from Gardenia Fructus; and flavone derivatives baicalin and wogonin (Figs. 1B, C) from Scutellaria baicalensis.
Effects of Kampo Medicines on Adipogenesis in Cultured RWPA We first investigated the in vitro effects of BOT, BTS and OGT on adipogenesis in RWPA. Cumulative lipogenesis was detected after 24 h of culture and increased until 48 h (Fig. 2C1) . However, no further increase in lipogenesis was observed when the cells were further cultured until 72 h (data not shown). As shown in Fig. 2A , all extracts at a concentration of 100 mg/ml significantly inhibited intracellular lipid accumulation by 55-67% at 24 and 48 h after differentiation of RWPA. These effects were concentrationdependent in the range of 1-100 mg/ml (Fig. 2B) . OGT seemed to be more effective than BTS and BOT (Fig. 2C4) . Although no data are shown, BOT, BTS and OGT at 10-100 mg/ml, representing sufficient concentrations of Kampo extracts to inhibit adipogenesis, showed no cytotoxicity against RWPA.
Overview of DNA Microarray Analyses of RWPA after Administration of Kampo Medicines At the same biological endpoints after administration of Kampo extracts, various mRNA expression levels were analyzed using a DNA microarray. After treatments with all extracts at 100 mg/ml for 24 h, total RNA extracts were prepared. Whole histograms of the expression profiles resembled one another among the groups, implying that our data sets were comparable. The Affymetrix Rat 230 2.0 microarray consists of 31099 probe sets, but not all of the values were useful for measurements. Noise values were eliminated based on the flag determined by the GCOS software after normalization to the median. Finally, we picked up 18364 useful probe sets. Since we carried out two experiments for each medicine, genes that showed Ն2-fold changes in their expression levels in both experiments were defined as upregulated or downregulated genes. DNA microarray analyses (total probe set: 31099) of cDNAs prepared from adipocytes revealed that BOT, BTS and OGT increased the expression of 133-150 genes and decreased the expression of 42-110 genes by Ն2-fold. The number of overlapping genes between BOT and BTS was 65. However, there were only 2 (for BOT) or 19 (for BTS) genes whose expression was upregulated in common with OGT (Fig. 3A) . On the other hand, very few commonly downregulated genes were detected. We clustered the data sets for upregulated or downregulated genes into a 2086 Vol. 31, No. 11 condition tree using the Pearson correlation method and the resultant heat map is shown in Fig. 3B . The hierarchical clustering analysis produced similar results to the Venn diagram shown in Fig. 3A . BOT and OGT were closely clustered while OGT was clustered separately (Fig. 3B) . Taken together, our results seem to imply that BOT and BTS have partial common effects on the gene expression profiles, whereas OGT does not. IPA uses a database depending on stored publications and enables us to identify functional regulatory networks from a gene list.
13) The gene list was used as a starting point for generating biological networks. To build these networks, the program uses its knowledge base to identify interactions between focus genes as well as other genes. IPA then determines a statistical score for each network according to the fit of the network to the set of focus genes. The score represents the negative log of p and denotes the likelihood of the focus genes in the network being found together due to chance (Fig. 3C) . Biological functions, such as lipid metabolism, were assigned to each gene network by using findings extracted from the scientific literature and stored in the Ingenuity Pathways Knowledge Base. The biological functions assigned to each network are ranked according to the significance of that biological function to the network. IPA has its own gene ontology, and we analyzed the upregulated or downregulated genes categorized as "lipid metabolism"-related functions in IPA. As shown in Table 2 , 10 genes affected by BOT, 20 genes affected by BTS and 22 genes affected by OGT were categorized into lipid metabolism-related functions. These genes seemed to coordinately affect lipid metabolism and result in the suppression of adipogenesis in RWPA. Several genes overlapped, as shown in Fig. 3A , but only OGT induced downregulation of multiple genes ( Table 2 ). We measured mRNA expression levels of seven selected genes highly contributing to the lipid metabolism, that were ACACA, AEBP1, PNPLA8, SCGB1A1, ADRB3, ADIPOQ, MGLL. The modulated genes shown in bold in Table 2 were applied to the RT-PCR analyses.
Confirmation Using Semiquantitative RT-PCR To further validate the IPA analysis, the mRNA expression levels of ACACA, AEBP1, PNPLA8, SCGB1A1, ADRB3, ADIPOQ, and MGLL, which fluctuated by Ͼ2-fold relative to the control, were examined by semiquantitative RT-PCR. The results revealed significant increases or decreases in these genes in RWPA, as shown in Fig. 4 .
DISCUSSION
In the present study, we have demonstrated that intracellular lipid accumulation in RWPA was significantly reduced over time by three different kinds of Kampo medicines in concentration-dependent manners. In a previous investigation, 15) we found that BOT inhibited obesity in ovariectomized rats. Nakayama et al. 16) recently reported that orally administered BTS lowered fatty acid droplet accumulation in the liver, and also reduced the levels of several plasma markers correlated to obesity as well as body growth in mice fed a high-fat diet. OGT contains four different herbs. Berberine, an isoquinoline alkaloid in Coptis rhizomes and Phellodendron cortex, is one of the major active constituents, and has been reported to have antihyperglycemic effects. [17] [18] [19] Therefore, adipocyte tissues represent one of the major target organs for the mechanisms by which BOT, BTS and OGT may prevent or improve obesity in vivo. To explore the mechanism of the anti-obesity effects of BOT, BTS and OGT, we exhaustively analyzed the mRNA expression levels in cultured RWPA after administration of these extracts using a DNA microarray at the same biological endpoints. In the cluster analysis, BOT and BTS downregulated and upregu- 
lated the expression levels of various genes in RWPA, and their gene regulatory patterns were similar. However, OGT showed a different gene regulatory pattern compared to those of BOT and BTS. These findings indicate that BTS and BOT target and modulate the expression of similar genes in RWPA in vitro. Furthermore, lipid metabolism-related genes were modulated by administration of these extracts. BOT and BTS individually upregulated 9 and 19 lipid-related genes, respectively, with ACACA, AEBP1, CXCL12 and PNPLA8 representing lipid metabolism-related genes upregulated by both extracts. Of these genes, ACACA, 20) AEBP1 21, 22) and PNPLA8 23, 24) were selected as determinants by the RT-PCR analyses, since the genes are reported to contribute to obesity through lipid metabolism. On the other hand, we measured mRNA expression levels of ADRB3 25) that was downregulated in the presence of BTS. This gene product, b-3 adrenalin receptor mainly observed in adipose tissue, is associated with liplid metabolism and thermal regulation. It is also known to related to activation of adenylate reductase induced by norepinephrine.
Interestingly, C3, PLA2G2A and PTGES, which are also related to lipid metabolism, were genes affected by both BTS and OGT in RWPA. It can therefore be assumed that the inhibitory effects of BTS on adipogenesis are partly induced through changes in gene expression levels that overlap between BOT or OGT. On the other hand, OGT was found to not only upregulate the expression of 19 genes but also downregulate the expression of 10 genes, which may explain why the effects of OGT on adipogenesis are greater than those of BOT and BTS. In fact, we measured mRNA expression levels of upregulated SCGB1A1 26, 27) and downregulated ADIPOQ 23, 24) and MGLL 28) in the presence of OGT with RT-PCR method, that is contributing to lipid metabolism. ADIPOQ expressed in adipose tissue is structurally highly homologous to collagen X/VIII and complementary factor C1q. It is thought to be collagen-like secretory protein.
Triglyceride stored in fat and other cells is hydrolyzed into fatty acids and glycerol with MGLL and hormone-sensitive lipase. MGLL is also able to hydrolyze monoglyceride that is produced with metabolism of lipoprotein triglyceride. There are two limitations of poor reproducibility analyzed with this microarray and detailed mechanism of administerd drugs in our experiment, although we found the modulation of genes' expression related to differentiation of adipose cell and fat storage.
In summary, to the best of our knowledge, the present results provide the first evidence that three different herbal extracts, namely BOT, BTS and OGT, can suppress adipogenesis in cultured adipocytes, and that different regulatory genes corresponding to obesity are affected by the extracts. Hence, these herbal extracts may be useful for preventing or improving obesity in subjects who are clinically diagnosed with morbid obesity according to Kampo and genetic diagnoses. Kampo medicines could show potential pharmacological effects through transformation to active metabolites in the liver after their metabolism and absorption in the small intestine, [29] [30] [31] [32] [33] although confirmation of these effects using both in vitro and in vivo experiments is necessary. 34) We are currently planning to investigate the effects of in vivo administration of BOT, BTS and OGT on obesity in mice fed a highfat diet, although it is also important to further clarify the usefulness of these three Kampo medicines in randomized control trials in clinical settings.
